Influenza Diagnostics Market is expected to reach $1.6 Bn by 2031

Global Influenza Diagnostics Market report from Global Insight Services is the single authoritative source of intelligence on Influenza Diagnostics Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Download Free Sample of Report - https://www.globalinsightservices.com/request-sample/GIS10306

The global influenza diagnostics market was valued at USD 0.9 billion in 2021 and it is anticipated to grow further till USD 1.6 billion by 2031, at a CAGR of 5.9% during the forecast period.

The influenza virus is the infectious disease that causes influenza, also referred to as "the flu." Flu is identified and diagnosed using a variety of conventional and molecular diagnostic tools. Modern technology is able to diagnose influenza quite effectively and precisely. For instance, the real-time molecular test known as the reverse transcription-polymerase chain reaction (RT-PCR) allows for the identification of influenza genetic material. Furthermore, due of its quick results and simple specimen collection, rapid influenza diagnostic testing (RIDT) has become an efficient approach for diagnosis.

Market Trends and Drivers

R&D efforts for better detection and diagnosis of influenza have intensified due to its rising frequency globally. The majority of research efforts concentrate on creating quicker and more precise diagnostic tools for influenza viruses, which will spur market expansion.

Report Overview- https://www.globalinsightservices.com/reports/influenza-diagnostics-market/

Similarly, Numerous assays and technologies helpful for the diagnosis and treatment of influenza infections have been developed as a result of the enormous quantity of data produced by the Human Genome Project and developments in molecular and biomedical technologies. These new genomic and proteomic technologies, such as microarray-based detection and PCR-based approaches, aid in the identification of novel influenza viruses. Additionally, they allow for quicker and better surveillance of infectious diseases, which presents a business opportunity.

Global Influenza Diagnostics Market by End User

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest share of the global influenza diagnostics market. The North American influenza diagnostics markets growth is primarily attributed to the growth in influenza research for diagnostic technologies and increasing prevalence of influenza.

Major Players in the Global Influenza Diagnostics Market

The key players in the market are Danaher Corporation (US), Siemens Healthineers (Germany), Thermo Fisher Scientific, Inc. (US), F. Hoffmann-LA Roche AG (Switzerland), Abbott Laboratories, Inc. (US), Hologic, Inc. (US), bioMérieux SA (France), Quidel Corporation (US), Becton, Dickinson and Company (US), Meridian Bioscience (US), GenMark Diagnostics, Inc. (US), Luminex Corporation (US), Tecan Trading AG (Switzerland), DiaSorin SA (Italy), and altona Diagnostics GmbH (Germany) among others.

Free Customization Available - https://www.globalinsightservices.com/request-customization/GIS10306

COVID-19 Impact

The onset of the COVID-19 pandemic has altered how medical treatment is provided globally. The COVID-19 pandemic has had a substantial impact on the market for influenza diagnostics; unfavorable changes in rules and standards, the closure of factories owing to lockdowns, and interruptions in supply chains have all had a negative impact on market growth. The availability of influenza diagnostics products to end customers has also been affected by restricted operations in the majority of businesses, insufficient funding for academic and research institutions, and difficulties in delivering necessary or post-sale services because of lockdowns.

Additionally, there are significant parallels between COVID-19 and influenza; both COVID-19 and seasonal flu (influenza A and B) are infectious viruses and exhibit similar respiratory illness symptoms. Infection outbreaks typically happen between December and February. The COVID-19 outbreak happened at the same time as the flu season, which led to a rise in the use of influenza tests at that time. Despite the difficult situation, supply and distribution channels have restarted, and industries are gradually recovering from the damage.

Purchase This Market Research Report - https://www.globalinsightservices.com/inquiry-before-buying/GIS10306

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

This release was published on openPR.